Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Citric Acid Cycle: Output01:28

The Citric Acid Cycle: Output

11.0K
The citric acid cycle is termed an amphibolic pathway as it operates both anabolically and catabolically. The cyclic reactions balance the flux of the substrates to provide an optimal concentration of NADH and ATP to the cell.
Regulation of Citric Acid Cycle
The citric acid cycle is regulated in several ways, including feedback inhibition, regulation of enzyme activities, and associated anaplerotic or cataplerotic pathways.
The primary substrate of the TCA cycle—acetyl CoA—is...
11.0K
The Citric Acid Cycle: Overview01:37

The Citric Acid Cycle: Overview

24.2K
In aerobic organisms, the citric acid cycle is the second stage of cellular respiration wherein molecules derived from the breakdown of carbohydrates, proteins, and fats are oxidized into carbon dioxide and energy. This process is also known as the tricarboxylic acid (TCA) cycle as the first product of the cycle, citric acid, contains three carboxyl groups in its structure. Alternatively, this cycle is also referred to as the Krebs cycle, in honor of its discoverer Sir Hans Krebs.
The citric...
24.2K
The Citric Acid Cycle02:36

The Citric Acid Cycle

164.0K
The citric acid cycle, also known as the Krebs cycle or TCA cycle, consists of several energy-generating reactions that yield one ATP molecule, three NADH molecules, one FADH2 molecule, and two CO2 molecules.
164.0K
Products of the Citric Acid Cycle00:53

Products of the Citric Acid Cycle

104.3K
The cells of most organisms—including plants and animals—obtain usable energy through aerobic respiration, the oxygen-requiring version of cellular respiration. Aerobic respiration consists of four major stages: glycolysis, pyruvate oxidation, the citric acid cycle, and oxidative phosphorylation. The third major stage, the citric acid cycle, is also known as the Krebs cycle or tricarboxylic acid (TCA) cycle.
104.3K
Respiration Pathways01:26

Respiration Pathways

847
Cellular respiration is a fundamental metabolic process that enables organisms to generate energy from organic molecules. One of its central pathways is the tricarboxylic acid (TCA) cycle, also known as the Krebs cycle, which plays a crucial role in energy production and biosynthetic processes.Conversion of Pyruvate to Acetyl-CoAThe pyruvate generated from glycolysis undergoes oxidative decarboxylation by the pyruvate dehydrogenase complex, producing acetyl-CoA, one molecule of NADH, and one...
847
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

14.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
14.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Potentially Surgical Digestive Complications in Patients With Status Epilepticus: Insights From the ICTAL Registry.

Critical care medicine·2026
Same author

Predictors of brain death after hanging-induced cardiac arrest.

Resuscitation·2026
Same author

Correction: Belfeki et al. State of the Art of Cardiac Amyloidosis. <i>Biomedicines</i> 2023, <i>11</i>, 1045.

Biomedicines·2026
Same author

Health-Related quality of life after status epilepticus: A cross-sectional study from the ICTAL registry.

Epilepsy & behavior : E&B·2025
Same author

Effect of half-dose thrombolysis on hypoxemia duration in intermediate risk pulmonary embolism.

Journal of thrombosis and thrombolysis·2025
Same author

Inhaled Sedation in Acute Respiratory Distress Syndrome: The SESAR Randomized Clinical Trial.

JAMA·2025
Same journal

Therapeutic plasma exchange and immunomodulatory strategies in post-infectious syndromes: A review of immune dysregulation in PTLDS, long COVID, ME/CFS, and PANS/PANDAS.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026
Same journal

Therapeutic plasma exchange in Alzheimer's disease: From clinical trial to real-world evidence.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026
Same journal

Successful treatment of pure red cell aplasia with Orelabrutinib following major ABO-incompatible hematopoietic stem cell transplantation for acute myeloid leukemia: A case report.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026
Same journal

Technological advances in selective plasma adsorption: The MTx.100 column and the emergence of subtractive precision medicine.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026
Same journal

What's happening? Editorial comment: Insights on artificial intelligence, cell therapy and stem cell transplantation safety.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026
Same journal

Red blood cell transfusion in elderly patients: Hemoglobin thresholds and clinical outcomes.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026
See all related articles

Related Experiment Video

Updated: Mar 9, 2026

Quantification of Coenzyme A in Cells and Tissues
08:51

Quantification of Coenzyme A in Cells and Tissues

Published on: September 27, 2019

9.0K

Citrate pathophysiology and metabolism.

Mehran Monchi1

  • 1Intensive care deparment, Centre Hospitalier de Melun, Melun, F-77000, France.

Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
|January 12, 2017
PubMed
Summary
This summary is machine-generated.

Citrate anticoagulation effectively prevents bleeding during extracorporeal circuits by chelating calcium. However, it can cause hypocalcemia, leading to QT prolongation and hypotension, especially in patients with cirrhosis.

Keywords:
AnticoagulationCitrateExtra corporeal circuitsPharmacodynamicsToxicity

More Related Videos

LC-MS Analysis of Human Platelets as a Platform for Studying Mitochondrial Metabolism
06:04

LC-MS Analysis of Human Platelets as a Platform for Studying Mitochondrial Metabolism

Published on: April 4, 2016

11.8K
Metabolic Pathway Confirmation and Discovery Through 13C-labeling of Proteinogenic Amino Acids
07:26

Metabolic Pathway Confirmation and Discovery Through 13C-labeling of Proteinogenic Amino Acids

Published on: January 26, 2012

25.1K

Related Experiment Videos

Last Updated: Mar 9, 2026

Quantification of Coenzyme A in Cells and Tissues
08:51

Quantification of Coenzyme A in Cells and Tissues

Published on: September 27, 2019

9.0K
LC-MS Analysis of Human Platelets as a Platform for Studying Mitochondrial Metabolism
06:04

LC-MS Analysis of Human Platelets as a Platform for Studying Mitochondrial Metabolism

Published on: April 4, 2016

11.8K
Metabolic Pathway Confirmation and Discovery Through 13C-labeling of Proteinogenic Amino Acids
07:26

Metabolic Pathway Confirmation and Discovery Through 13C-labeling of Proteinogenic Amino Acids

Published on: January 26, 2012

25.1K

Area of Science:

  • Nephrology
  • Hematology
  • Critical Care Medicine

Background:

  • Citrate anticoagulation is a widely used method in extracorporeal circuits, offering an alternative to heparin.
  • It functions by chelating ionized calcium, thereby inhibiting the coagulation cascade.
  • Citrate anticoagulation is associated with reduced activation of leukocytes and platelets.

Purpose of the Study:

  • To evaluate the efficacy and safety of citrate anticoagulation in extracorporeal circuits.
  • To investigate the impact of citrate on patient anticoagulation and bleeding risk.
  • To explore the metabolic fate and potential toxic effects of citrate, particularly in patients with renal impairment or liver cirrhosis.

Main Methods:

  • Review of existing literature on citrate anticoagulation in extracorporeal circuits.
  • Analysis of citrate pharmacokinetics and its clearance mechanisms, including the citric acid cycle (Krebs cycle).
  • Examination of citrate's effects on ionized calcium levels, coagulation parameters, and potential adverse events like hypocalcemia and QT interval prolongation.

Main Results:

  • Citrate effectively achieves anticoagulation in extracorporeal circuits without increasing the patient's bleeding risk.
  • Citrate anticoagulation demonstrates a reduced activation of leukocytes and platelets compared to other anticoagulation methods.
  • Citrate clearance via the citric acid cycle is unaffected by renal failure but is significantly reduced (by approximately 50%) in patients with cirrhosis.
  • Toxic citrate effects are primarily linked to a decrease in plasma ionized calcium, with clinical signs of hypocalcemia and hypotension observed below 0.9 mmol/L.

Conclusions:

  • Citrate anticoagulation is a safe and effective method for extracorporeal circuits, minimizing bleeding complications.
  • Patient factors, particularly liver cirrhosis, can significantly impair citrate metabolism, increasing the risk of toxicity.
  • Close monitoring of ionized calcium levels is crucial to prevent adverse events such as QT prolongation and hypotension in patients undergoing citrate anticoagulation.